ResMed Inc (RMD)
Debt-to-equity ratio
| Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 5,967,860 | 4,864,040 | 4,129,900 | 3,360,750 | 2,885,680 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
June 30, 2025 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $5,967,860K
= 0.00
Based on the provided data, ResMed Inc exhibits a debt-to-equity ratio of zero across all the specified periods—from June 30, 2021, through June 30, 2025. This consistency indicates that the company has maintained an entirely equity-financed capital structure throughout this timeframe. The absence of debt suggests that ResMed Inc relies solely on shareholders’ equity to finance its operations and growth initiatives. Such a capital structure implies a low financial leverage profile, likely reducing the company's financial risk and interest obligations. Consequently, the company does not face the typical financial pressures associated with debt servicing, potentially enabling a more flexible strategic operational framework.
Peer comparison
Jun 30, 2025